종목코드 | 종목명 | 수량 | 평가금액(원) | 비중(%) |
---|---|---|---|---|
LLY US EQUITY | Eli Lilly & Co | 62 | 64,905,165 | 16.02 |
NTRA US EQUITY | Natera Inc | 91 | 20,633,886 | 5.09 |
EXEL US EQUITY | Exelixis Inc | 273 | 16,094,578 | 3.97 |
NVO US EQUITY | Novo Nordisk A/S | 163 | 15,075,625 | 3.72 |
ABBV US EQUITY | AbbVie Inc | 60 | 14,767,110 | 3.65 |
JNJ US EQUITY | Johnson & Johnson | 70 | 14,402,745 | 3.56 |
ALNY US EQUITY | Alnylam Pharmaceuticals Inc | 33 | 14,382,076 | 3.55 |
ABT US EQUITY | Abbott Laboratories | 79 | 14,331,627 | 3.54 |
NVS US EQUITY | Novartis AG | 88 | 14,257,188 | 3.52 |
LDOS US EQUITY | Leidos Holdings Inc | 60 | 12,610,080 | 3.11 |
RELX US EQUITY | RELX PLC | 173 | 12,564,990 | 3.10 |
TEVA US EQUITY | Teva Pharmaceutical Industries Ltd | 545 | 12,331,170 | 3.04 |
SNY US EQUITY | Sanofi SA | 184 | 11,885,940 | 2.93 |
GSK US EQUITY | GSK PLC | 218 | 11,354,094 | 2.80 |
AMGN US EQUITY | Amgen Inc | 30 | 11,223,765 | 2.77 |
VTRS US EQUITY | Viatris Inc | 905 | 11,007,967 | 2.72 |
QGEN US EQUITY | QIAGEN NV | 161 | 10,382,809 | 2.56 |
298380 | 에이비엘바이오 | 150 | 10,080,000 | 2.49 |
AZN US EQUITY | AstraZeneca PLC | 105 | 9,901,237 | 2.44 |
347850 | 디앤디파마텍 | 82 | 9,717,000 | 2.40 |
BAX US EQUITY | Baxter International Inc | 230 | 9,436,095 | 2.33 |
TAK US EQUITY | Takeda Pharmaceutical Co Ltd | 437 | 8,908,245 | 2.20 |
PFE US EQUITY | Pfizer Inc | 254 | 8,294,751 | 2.05 |
TMO US EQUITY | Thermo Fisher Scientific Inc | 15 | 8,267,670 | 2.04 |
141080 | 리가켐바이오 | 70 | 8,036,000 | 1.98 |
IQV US EQUITY | IQVIA Holdings Inc | 34 | 7,227,873 | 1.78 |
BIIB US EQUITY | Biogen Inc | 40 | 6,808,320 | 1.68 |
REGN US EQUITY | Regeneron Pharmaceuticals Inc | 9 | 6,330,150 | 1.56 |
BMY US EQUITY | Bristol-Myers Squibb Co | 101 | 6,319,822 | 1.56 |
RVTY US EQUITY | Revvity Inc | 44 | 5,810,508 | 1.43 |
TEM US EQUITY | Tempus AI Inc | 55 | 4,939,110 | 1.22 |
128940 | 한미약품 | 15 | 4,290,000 | 1.06 |
196170 | 알테오젠 | 11 | 4,092,000 | 1.01 |
MRK US EQUITY | Merck & Co Inc | 27 | 2,883,195 | 0.71 |
현금 | 1,603,934 | 1,603,934 | 0.40 |
구분 | 1주 | 1개월 | 3개월 | 6개월 | 1년 | 3년 | 연초 이후 | 상장 이후 |
---|---|---|---|---|---|---|---|---|
기준가 | -1.89 | -2.14 | -9.30 | -11.70 | - | - | -11.70 | -18.56 |
비교지수 | -2.48 | 0.27 | -11.65 | -13.33 | - | - | -12.27 | -15.19 |
초과성과 | 0.59 | -2.42 | 2.35 | 1.63 | - | - | 0.57 | -3.37 |
일자 | 기준가격(원) | 시장가격(원) | 과표기준가(원) | ||
---|---|---|---|---|---|
기준가격(원) | 등락률(%) | 종가(원) | 등락률(%) | ||
2025.07.01 | 8,160.32 | 0.71 | 8,110.00 | -0.43 | 0.00 |
2025.06.30 | 8,103.13 | -1.07 | 8,145.00 | -1.57 | 8,073.67 |
2025.06.27 | 8,190.52 | 0.26 | 8,275.00 | 0 | 8,154.81 |
2025.06.26 | 8,169.24 | -0.94 | 8,275.00 | 0.73 | 8,128.24 |
2025.06.25 | 8,247.17 | 1.42 | 8,215.00 | 0.31 | 8,200.25 |
2025.06.24 | 8,132.07 | -1.54 | 8,190.00 | -0.06 | 8,078.40 |
2025.06.23 | 8,259.38 | 0.4 | 8,195.00 | -0.3 | 8,195.70 |
2025.06.20 | 8,226.52 | -0.92 | 8,220.00 | 0 | 8,137.49 |
2025.06.19 | 8,303.01 | 0.75 | 8,220.00 | -0.42 | 8,219.64 |
2025.06.18 | 8,241.53 | -1.58 | 8,255.00 | -0.72 | 8,178.64 |
2025.06.17 | 8,374.16 | -0.28 | 8,315.00 | -0.3 | 8,290.80 |
2025.06.16 | 8,397.74 | -0.7 | 8,340.00 | 0.79 | 8,322.55 |
2025.06.13 | 8,456.83 | 1.17 | 8,275.00 | -2.13 | 8,410.67 |
2025.06.12 | 8,359.32 | -1.22 | 8,455.00 | 0.96 | 8,272.86 |
2025.06.11 | 8,462.84 | 2.33 | 8,375.00 | 1.52 | 8,381.33 |
2025.06.10 | 8,270.14 | 1.31 | 8,250.00 | 1.73 | 8,198.05 |
2025.06.09 | 8,162.90 | 0.46 | 8,110.00 | 0 | 8,118.61 |
2025.06.05 | 8,125.67 | -0.2 | 8,110.00 | -0.25 | 8,083.98 |
2025.06.04 | 8,141.56 | -1.46 | 8,130.00 | -1.03 | 8,080.99 |
2025.06.02 | 8,262.45 | -0.22 | 8,215.00 | 0.06 | 8,075.15 |
운용 | AP/LP | 수탁 | 사무수탁 | 총보수(연%) |
---|---|---|---|---|
0.69% | 0.04% | 0.04% | 0.03% | 총 0.80% |